How to take Pembrolizumab

Pembrolizumab is administered by intravenous infusion, and in some cases patients will need to have their PD-L1 or MSI H/dMMR tumor status checked before starting treatment. Pembrolizumab is available by prescription only, and treatment must be started and supervised by a doctor experienced in treating cancer.

The recommended dose of pembrolizumab in adults is 200 mg every three weeks or 400 mg every six weeks until disease progression, unacceptable toxicity, or up to 24 months in patients without disease progression. The pembrolizumab dose for children and adolescents is 2 mg/kg, up to a maximum of 200mg. If a patient develops certain side effects while using this medicine, including flushing, fever, chills, tremors, dizziness, dizziness, shortness of breath, difficulty breathing, back pain, itching, rash, or hives, the doctor may delay the dose or stop treatment entirely if the side effects are severe.

PembrolizumabThe original drug is already on the market in China. SpecificationsThe price per box of 100mg/4ml may be around RMB 15,000. This drug is a strictly controlled drug and has not yet been included in medical insurance. Pembrolizumab The price of the European version of the original drug 100mg/4ml per box may be around RMB 25,000, and the price of the Turkish version of 100mg/4ml per box may be around 10,000 RMB (the price may fluctuate due to the exchange rate). The ingredients of the original drugs at home and abroad are basically the same, and they are expensive. There are currently no generic versions of Pembrolizumab available overseas.